The top analyst has identified a bold answer as to why Cardano(ADA) will have a hard time hitting $18 and found another token that could achieve that easily. The token is cheaper than ADA and lucky enough, it is in presale stage 11, offering an early entry. The token is RXS from Rexas Finance, which focuses uniquely on real-world assets (RWA) tokenization where one token goes for $0.175 due to rise to $0.2. Its presale has been making headlines, and investors of all sizes, from low to whales, have been investing in the RXS presale. Analysts predict that RXS can easily reach the $18 price target due to the increased demand.

Can ADA reach $18? The challenge of an 18x market cap boost amid current Crypto dynamics

So, looking at the ADA’s current market cap, you can understand why it may struggle to reach $18. Cardano is currently worth about $33.78 billion. Of course, the real market cap would have to be astronomical, too, around $608.04 billion, to give ADA a price of $18. This is an 18x jump on top of its current valuation, a feat that appears impossible to achieve in the current market environment and the sentiment it attracts. Despite recent bullish movements with a significant increase of 8.25% over the day, the overall sentiment towards ADA is cautious. Analysts expect that ADA can enjoy some growth. Still, it looks difficult for this coin to reach such a price without significant changes in market conditions or the attitude of investors.

RXS Gaining Momentum: Rexas Finance positioned as an ‘ADA Killer’ with $35M presale success and real-world asset Focus

Rexas Finance (RXS). As of this writing, RXS sits in Stage 11 of its presale at just $0.175 but is expected to rise to $0.20 shortly. RXS is gaining much momentum, and investors are beginning to see it as the ‘ADA killer. Rexas Finance focuses on real-world assets (RWA), giving it a good standing in the market. With RXS targeting a growing demand for decentralized finance solutions that use blockchain technology to access real-world applications, RXS focuses on bridging traditional assets with blockchain technology. This sets RXS up to challenge long-established players like Cardano using this innovative approach. Rexas Finance presale has been incredible, collecting around $35 million from the desired $41 million. With almost 91.95% of its total amount raised, RXS has already sold more than 390 million tokens out of its total reserve of 425 million, gaining immense popularity among those seeking crypto investment.

Furthermore, regarding visibility and credibility, RXS has made progress; it is listed on major cryptocurrency portals such as CoinMarketCap and CoinGecko and has received an audit from Certik, which largely increases the noise around its legitimacy and security.

https://twitter.com/rexasfinance/status/1857692542290059502

The Future for RXS and ADA

2025 is a bullish year for the crypto industry. Though the price for Cardano (ADA) is set to rise, achieving an $18 price point seems daunting based on the current crypto market, and it requires more than 18X  of its market cap to reach there. But for Rexas Finance analysts have predicted that $18  seems an easy reach for it based on the momentum where it has been selling out its presale stages very fast due to increased demand, currently in stage 11 where one RXS goes for $0.175 savvy investors should act fast before the price hikes to $0.2. 

Website: https://rexas.com

Whitepaper: https://rexas.com/rexas-whitepaper.pdf

Twitter/X: https://x.com/rexasfinance

Telegram: https://t.me/rexasfinance


DISCLAIMER –Views Expressed Disclaimer: This article is not financial advice. Cryptocurrencies are volatile and unpredictable. Due diligence and caution are paramount. Views and opinions expressed are those of the authors and do not reflect the official position of any other author, agency, organization, employer or company, including NEO CYMED PUBLISHING LIMITED, which is the publishing company performing under the name Cyprus-Mail…more